Strive prices $630 million preferred stock offering at $90

Strive priced an offering of 7 million Series A perpetual preferred shares at $90 each, estimating gross proceeds of about $630 million before underwriting discounts and commissions. The shares accrue cumulative dividends at 15% annually on a stated $100 per share, and the company plans to use net proceeds for general corporate purposes, including bitcoin-related acquisitions and potential share repurchases. Strive will fund an $22.50-per-share dividend reserve, equivalent to 18 months of payments, at closing.

Analysis

This is capital access, but at a potentially punitive marginal cost: the $15 annual dividend against a $90 issue price implies a 16.7% cash cost on proceeds, before fees, while the cumulative feature means unpaid distributions continue to accrue. The $22.50-per-share reserve also earmarks existing liquidity rather than creating deployable capital. If proceeds fund bitcoin exposure or other assets earning less than this cost, the preferred structure transfers value from common shareholders to senior capital; using proceeds for common buybacks would be especially hard to justify absent a large discount to intrinsic value. The stated liquidation preference’s daily trading-based adjustment makes the preferred’s payoff less straightforward than a conventional par instrument; confirm mechanics in final documents.

Near term, watch settlement on October 20 and disclosures on actual net proceeds and use. Over 1–3 months, the first dividend declaration and evidence of asset purchases or buybacks will reveal whether this is productive financing or expensive balance-sheet engineering. Over 6–18 months, sustained bitcoin weakness or asset returns below the financing cost could pressure common equity and refinancing flexibility. A reserve provides a near-term cushion, not a durable solution. The contrarian point: a successful raise demonstrates access to capital, but not that the resulting investment earns its cost. Falsifiers include verified returns comfortably above the effective financing cost, disciplined use of proceeds, or a materially different final preferred-price formula.

Key Decisions for Investors

• Treat the raise as a negative quality-of-capital signal for ASST common until proceeds deployment and the full capital-stack impact are clear; do not interpret gross proceeds as equivalent to incremental common-equity value.
• For a tactical expression, consider underweighting ASST versus direct bitcoin exposure rather than making an outright short: the relative view is that the preferred claim and high distribution burden may dilute common-equity participation. Check ASST’s bitcoin sensitivity, borrow availability, and the final SATS terms before sizing; thesis weakens if asset returns demonstrably exceed the financing cost.
• Track the October 20 closing, net proceeds after fees, the source of the dividend reserve, and the first dividend declaration. Reassess if proceeds are directed to common buybacks or if the company provides no measurable return framework for acquisitions and bitcoin-related assets.
• No trade based solely on the underwriting roles of BRC Group Holdings, StoneX Group, or Barclays; the article provides no evidence that this transaction is material to their earnings.